Commentary
Nature Nanotechnology 3, 242 - 244 (2008)
doi:10.1038/nnano.2008.114
Subject Category: Nanomedicine
Seven challenges for nanomedicine
Wendy R. Sanhai1, Jason H. Sakamoto2, Richard Canady3 & Mauro Ferrari2,4,5
- The Office of the Commissioner, Food & Drug Administration, Rockville, Maryland 20857, USA
- Nanomedicine, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
- Office of Science and Health Coordination, Food & Drug Administration, Rockville, Maryland 20857, USA
- Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
- Department of Bioengineering, Rice University, Houston, Texas 77005, USA.
Correspondence to: Mauro Ferrari2,4,5 e-mail: mauro.ferrari@uth.tmc.edu
Abstract
Nanomedicine offers new opportunities to fight diseases but a global effort is needed to safely translate laboratory innovation to the clinic. Seven priority areas have been identified for this endeavour.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
